![]() |
|
|
,**




* School of Natural Resources, The Ohio State University, Columbus, OH 43210;
AKVAFORSK, Institute of Aquaculture Research, Sunndalsøra, Norway;
** Aquaculture Protein Centre, Ås, Norway;
Department of Aquatic Life Medicine, College of Ocean Science and Technology, Kunsan National University, Soryong-Dong, Kunsan City, Chonbuk, South Korea; and

São Paulo State University Aquaculture Center, Jaboticabal-SP, Brazil
2To whom correspondence should be addressed. E-mail: dabrowski.1{at}osu.edu.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: teleost lipoic acid ascorbic acid antioxidant free amino acids
The antioxidant
-lipoic acid (1), 1,2-dithiolane-3-pentanoic acid (C8H14O2S2), is both water and lipid soluble, and is present in pro- and eukaryotic organisms (2). In mammals, the R isomer is synthesized by lipoic acid (LA)3 synthase (3,4). LA protects several macromolecules against reactive oxygen species (ROS) (5), and exerts its effects mainly through its reduced form, dihydrolipoic acid, a conversion catalyzed by lipoamide dehydrogenase. Through linkage between its carboxyl group and lysine residues in proteins, LA is an essential cofactor for mitochondrial enzymes, pyruvate dehydrogenase, glycine decarboxylase,
-keto glutarate dehydrogenase, and branched chain
-keto dehydrogenase (3,6).
Ascorbic acid (AA) is known for its antioxidant capacity through its actions, for example, on ROS in biological fluids and membranes. Deficiency indicators in scurvy-prone teleost fish include reduced feed efficiency and growth, muscular dystrophy, scoliosis, lens cataracts, and hemorrhages (7). The effects of AA on plasma free amino acid (FAA) levels were investigated (8) in humans, and significant effects of high AA intake manifested differently depending on the particular amino acid in question. For instance, leucine and lysine were elevated, whereas arginine, glutamic acid, and glycine were significantly depressed in plasma (8). There is little information on the effects of LA on general amino acid and nitrogen metabolism in mammals; most research has focused on interactions with ROS, and lipid and carbohydrate metabolism. However, LA-containing enzymes were shown to facilitate BCAA oxidation in plants (9), and humans deficient in lipoamide dehydrogenase develop higher levels of branched-chain FAA in plasma (10). Cats have a low tolerance for LA compared with other mammals, and a high dose led to disrupted plasma and tissue FAA profiles compared with controls (11).
Due to the antioxidant properties of LA and its many positive effects in the treatment of hypertension and diabetes in mammals (4,12), there may be potential for its use as a supplement in fish nutrition. Indiscriminate use of LA, however, was shown to be adverse for cats (11), and the similar carnivorous nature of many cultured teleost species necessitates that studies address several effects of this potential supplement. To our knowledge, neither the metabolism nor the effects or requirements of dietary LA have been studied in fish. Due to the pivotal role of amino acids in the general metabolic pathways in fish (13) and the scarce knowledge of the effects of LA and AA on fish nitrogen metabolism, we address here the effects of these antioxidants on plasma FAA. We studied the South American fish pacu (Piaractus mesopotamicus), which is increasingly being used in aquaculture due to its good consumer acceptance and high growth rate (14).
| MATERIALS AND METHODS |
|---|
|
|
|---|
-lipoic acid, Sigma, T5625) was provided at 0 or 1 g/kg diet (using dextrin for replacement). LA supplementation was chosen to be below levels given to rats (16) due to the lower metabolic rate in fish and the long study period required to achieve multiples of initial body weight. Diets were mixed, pelleted, and freeze-dried to obtain pellets of desired sizes.
|
Analysis. Samples were prepared by diluting plasma with 1:1 (v:v) of 0.1 mol/L HCl containing 200 µmol/L norleucine internal standard (norleucine recovery was 102 ± 11%) (17). Samples were subsequently filtered with Millipore Ultrafree-MC filtration devices (10-kDa cutoff at 2000 x g, 4°C, 90 min). Aliquots of blanks and external standards (Sigma acid/neutral and basic amino acids), the latter supplemented with glutamine, were prepared at the same time by mixing with distilled and deionized H2O, 0.1 mol/L HCl, and norleucine. Samples, standards, and blanks were then stored at 80°C for later analysis. Amino acids were precolumn derivatized with phenylisothiocyanate (17); in addition, we found that derivatized fish plasma samples required a final centrifugation step (10 min, 9000 x g) before injection to remove precipitates. FAA were quantified using a Waters PicoTag RP-HPLC equipped with an application-specific FAA column (3.9 x 30 cm), a Waters 717 autosampler set at 10°C, models 501 pumps, 441 absorbance detector at 254 nm, a gradient controller, and a Waters column heater at 46°C. Integration through the 87-min runs was conducted by ChromPerfect software (Justice Laboratory Software). Eluents, purchased premixed and ready for use (Eluent 1, 2, Waters), were employed throughout. Amino acids were identified from samples spiked with known FAA and from retention times of standards run every 4th sample. Reported cystine values include cystine plus cysteine. Asparagine was detected, but at very low levels, and eluted as a small peak between and close to both the serine and glycine peaks; thus, it was judged not to be quantifiable under these conditions and amino acid profile characteristics. Plasma FAA concentrations (µmol/L) were calculated using both the internal and external standards (17).
Data analysis. Data are presented as means ± SD. The percentage change was calculated for LA across AA groups and vice versa. Established nomenclature used for indispensable free amino acids (IDAA) and dispensable free amino acids (DAA) in fish was followed (18). Tanks were used as the experimental unit, and no data transformation was conducted. Data, in µmol/L for the FAA, were tested using SPSS version 12.0.1 throughout, except for nonparametric tests (19). Data were tested for homogeneity of variances by Levenes test. If significant, the nonparametric Kruskal-Wallis test extended for 2-way designs (19) was used to ensure that any significance matched that of the 2-way univariate general linear model (GLM) tests. This occurred in all cases, and effects of LA and AA, and their interactions, were therefore tested by 2-way univariate GLMs. When significant (P < 0.05), Duncans multiple comparison tests in the 1-way ANOVA SPSS post-hoc procedure were used.
| RESULTS |
|---|
|
|
|---|
Dietary LA significantly reduced total plasma FAA concentrations (Fig. 1, Table 2). DAAs were most affected, with plasma concentrations declining
20%. For 7 of the 13 individual DAA, the decline in concentration was significant, and serine was the DAA most affected by LA dietary treatment (Fig. 1, Table 2). The finding of a significant dietary influence of LA on total FAA levels persisted if proline, which dominated the FAA plasma pool, was excluded from the dataset. Several of the IDAA concentrations tended to decrease with LA supplementation (P = 0.090.33) (Table 2, , 3). The branched-chain:aromatic amino acid ratios, indicators of adverse metabolic effects of LA were not affected by LA dietary treatment (P > 0.05). Of the sulfur amino acids, LA increased circulating cystine significantly (Table 2) above the level without LA in the diet.
|
|
|
AA had a smaller effect upon the total FAA and most individual FAA concentrations than did LA; no significant interactions between the 2 supplements were detected (Table 2). However, AA significantly decreased taurine concentrations compared with the level without AA supplementation, and a similar trend was observed for cystathionine (Fig. 1, Table 2).
| DISCUSSION |
|---|
|
|
|---|
Sulfur amino acids were affected differently than most other amino acids upon LA supplementation. Methionine did not show the decline typical for most IDAA (Table 3). Cystathionine was unaffected by LA treatment, whereas cystine was significantly elevated, and taurine, which is synthesized from cysteine (22), was decreased (Fig. 1). These findings suggest that either LA treatment affected cystine transport out of plasma and/or that total cellular cystine synthesis increased relative to catabolism. Notably, mammalian studies show that LA increases cysteine levels both in vivo and in vitro (23,24). The dietary level of AA used here had no significant effects on most plasma FAA, unlike what was reported for a scurvy-prone mammal at high dosage (8). AA, like LA, did affect plasma sulfur amino acids; however, there was a considerable reduction in both cystathionine and taurine levels in the pacu (Fig. 1). In humans, an opposite response was seen for taurine, and methionine decreased (8). Taurine has antioxidant properties at physiologic concentrations (22,25) and its essentiality in the early life stages of marine fish was suggested (26). Future experiments should investigate whether there exists an interaction between dietary taurine and AA on antioxidant capacity in fish.
It was expected that an interaction between LA and AA would have been detected in the present study because LA is able to recycle AA (27), but this did not occur. However, in the same experimental fish used here, LA decreased the rate of AA depletion in hepatic and gill tissues in pacu fed diets devoid of ascorbate (28). The lack of an interaction effect has not been explained.
Although it is not known to what degree teleost fish can synthesize LA endogenously, LA is likely present predominately as lipoyl-lysine in commercial aquaculture diets rich in fish ingredients. However, there is currently a trend toward replacing fish meal and fish oils with vegetable sources in aquaculture nutrition. Because plant tissues generally have a low LA content compared with animal tissues (2), situations with a higher risk of accumulating ROS, as in concurrent use of high-energy diets rich in lipids (29), could make LA dietary supplementation advantageous. As demonstrated for pacu at these dietary antioxidant and lipid levels, however, both LA and AA have a significant effect on plasma FAA concentrations, and this effect targets especially dispensable and sulfuric amino acids. Thus, when formulating and testing future diets supplemented with LA, protein utilization indices such as PER, apparent net protein utilization, and expression of central enzymes of nitrogen metabolism should be monitored closely. It will also be of interest to investigate the effects of LA on the metabolism of other compound classes in fish, e.g., the carbohydrates.
| FOOTNOTES |
|---|
3 Abbreviations used: AA, ascorbic acid; DAA, dispensable free amino acids; FAA, free amino acids; FCR, feed conversion ratio; IDAA, indispensable free amino acids; LA, lipoic acid; PER, protein efficiency ratio; ROS, reactive oxygen species. ![]()
Manuscript received 20 July 2004. Initial review completed 3 August 2004. Revision accepted 13 August 2004.
| LITERATURE CITED |
|---|
|
|
|---|
1. Reed, L. (2001) A trail of research from lipoic acid to
-keto acid dehydrogenase complexes. J. Biol. Chem. 276:38329-38336.
2. Navari-Izzo, F., Quartacci, M. & Sgherri, C. (2002) Lipoic acid: a unique antioxidant in the detoxification of activated oxygen species. Plant Physiol. Biochem. 40:463-470.
3. Morikawa, T., Yasuno, R. & Wada, H. (2001) Do mammalian cells synthesize lipoic acid? Identification of a mouse cDNA encoding a lipoic acid synthase located in mitochondria. FEBS Lett. 498:16-21.[Medline]
4. Wollin, S. & Jones, P. (2003)
-Lipoic acid and cardiovascular disease. J. Nutr. 133:3327-3330.
5. Yilmaz, O., Ozkan, Y., Yildirim, M., Ozturk, A. & Ersan, Y. (2002) Effects of alpha lipoic acid, ascorbic acid-6-palmitate, and fish oil on the glutathione, malonaldehyde, and fatty acids levels in erythrocytes of streptozotocin induced diabetic male rats. J. Cell. Biochem. 86:530-539.[Medline]
6. Fujiwara, K., Okamura-Ikeda, K. & Motokawa, Y. (1990) cDNA sequence, in vitro synthesis, and intramitochondrial lipoylation of H-protein of the glycine cleavage system. J. Biol. Chem. 265:17463-17467.
7. Lee, K.-J. & Dabrowski, K. (2003) Interaction between vitamins C and E affects their tissue concentrations, growth, lipid oxidation, and deficiency symptoms in yellow perch (Perca flavescens). Br. J. Nutr. 89:589-596.[Medline]
8. Tsao, C. & Miyashita, K. (1984) Effects of high intake of ascorbic acid on plasma levels of amino acids. ICRS Med. Sci. 12:1052-1053.
9. Taylor, N., Heazlewood, J., Day, D. & Millar, A. (2004) Lipoic acid-dependent oxidative catabolism of
-keto acids in mitochondria provides evidence for branched-chain amino acid catabolism in Arabidopsis. Plant Physiol. 134:838-848.
10. Craigen, W. (1996) Leigh disease with deficiency of lipoamide dehydrogenase: treatment failure with dichloroacetate. Pediatr. Neurol. 14:69-71.[Medline]
11. Hill, A., Werner, J., Rogers, Q., ONeill, S. & Christopher, M. (2004) Lipoic acid is 10 times more toxic in cats than reported in humans, dogs or rats. J. Anim. Physiol. Anim. Nutr. 88:150-156.[Medline]
12. Midaoui, A. & Champlain, J. (2002) Prevention of hypertension, insulin resistance, and oxidative stress by
-lipoic acid. Hypertension 39:303-307.
13. Dabrowski, K. & Guderley, H. (2002) Intermediary metabolism. Halver, J. E. Hardy, R. W. eds. Fish Nutrition 3rd ed. 2002:310-367 Academic Press San Diego, CA. .
14. Jomori, R., Carneiro, D., Malheiros, E. & Portella, M. (2003) Growth and survival of pacu Piaractus mesopotamicus (Holmberg, 1887) juveniles reared in ponds or at different initial larviculture periods indoors. Aquaculture 221:277-287.
15. Tesser, M., Dabrowski, K., Terjesen, B., Pizauro, J. & Portella, M. (2004) Free- and peptide-based arginine supplementation into arginine-deficient diets for South American fish, Piaractus mesopotamicus. World Aquaculture 2004, 27 March 2004 2004:63 Honolulu, HI.
16. Hagen, T., Ingersoll, R., Lykkesfeldt, J., Liu, J., Wehr, C., Vinarsky, V., Bartholomew, J. & Ames, A. (1999) (R)-
-Lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate. FASEB J. 13:411-418.
17. Cohen, S., Meys, M. & Tarvin, T. (1989) The Pico-Tag Method: A Manual of Advanced Techniques for Amino Acid Analysis 1989 Millipore Corporation Milford, MA.
18. Wilson, R. P. (2002) Amino acids and proteins. Halver, J. E. Hardy, R. W. eds. Fish Nutrition 3rd ed. 2002:143-179 Academic Press San Diego, CA. .
19. Zar, J. H. (1984) Biostatistical Analysis 2nd ed. 1984 Prentice-Hall London, UK.
20. Murai, T., Ogata, H., Takeuchi, T., Watanabe, T. & Nose, T. (1984) Composition of free amino acid in excretion of carp fed amino acid diets and casein-gelatin diets. Bull. Jpn. Soc. Sci. Fish. 50:1957-1958.
21. Hamano, Y., Sugawara, S., Kamota, Y. & Nagai, E. (1999) Involvement of lipoic acid in plasma metabolites, hepatic oxygen consumption, and metabolic response to ß-agonist in broiler chickens. Br. J. Nutr. 82:497-503.[Medline]
22. Huxtable, R. J. (1992) Physiological actions of taurine. Physiol. Rev. 72:101-163.
23. Han, D., Handelman, G., Marcocci, L., Sen, C., Roy, S., Kobuchi, H., Tritschler, H., Flohe, L. & Packer, L. (1997) Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization. Biofactors 6:321-338.[Medline]
24. Suh, J., Wang, H., Liu, R.-M., Liu, J. & Hagen, T. (2004) (R)-
-Lipoic acid reverses the age-related loss in GSH redox status in post-mitotic tissues: evidence for increased cysteine requirement for GSH synthesis. Arch. Biochem. Biophys. 423:126-135.[Medline]
25. Kilic, F., Bhardwaj, R., Caulfeild, J. & Trevithick, J. (1999) Modelling cortical cataractogenesis 22: is in vitro reduction of damage in model diabetic rat cataract by taurine due to its antioxidant activity?. Exp. Eye Res. 69:291-300.[Medline]
26. Takeuchi, T. (2001) A review of feed development for early life stages of marine finfish in Japan. Aquaculture 200:203-222.
27. Packer, L., Tritschler, H. & Wessel, K. (1997) Neuroprotection by the metabolic antioxidant
-lipoic acid. Free Radic. Biol. Med. 22:359-378.[Medline]
28. Park, K., Tesser, M., Terjesen, B., Zhang, Y., Portella, M. & Dabrowski, K. (2004) New purified-diet formulations for nutritional requirement studies in the tropical fish pacu, Piaractus mesopotamicus. VI International Congress on the Biology of Fishes. Fish Culture Performance in the Tropics Symposium, 15 August 2004 2004:15-19 Manaus, Brasil.
29. Sargent, J., Tocher, D. & Bell, J. (2002) The lipids. Halver, J. E. Hardy, R. W. eds. Fish Nutrition 3rd ed. 2002:181-257 Academic Press San Diego, CA. .
30. Dabrowski, K., Lee, K.-J. & Rinchard, J. (2003) The smallest vertebrate, teleost fish, can utilize synthetic dipeptide-based diets. J. Nutr. 133:4225-4229.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||